Estimating blood pressure of a subject using an ecg driven cardiovascular model

US2023397822A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023397822-A1
Application numberUS-202318332552-A
CountryUS
Kind codeA1
Filing dateJun 9, 2023
Priority dateJun 10, 2022
Publication dateDec 14, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure relates generally to in-silico modeling of hemodynamic patterns of physiologic blood flow. Conventional cardiovascular hemodynamic models depend on neuromodulation schemes (baroreflex autoregulation) and threshold parameters of neuromodulation correlate with physical activities. Thus these models may not work practically for a large set of people due to dependency on prior knowledge of these parameters. The present disclosure enables estimating blood pressure of a subject by estimating cardiac parameters based on the morphology of ECG signal associated with the subject and hence activation delays in cardiac chambers of the in-silico model is reproduced purposefully. In accordance with the present disclosure, the blood pressure of the subject can be estimated using only the ECG signal even if the signal is missed for some time instance(s) or is noisy.

First claim

Opening claim text (preview).

What is claimed is: 1 . A processor implemented method comprising: estimating, by an in-silico cardiovascular hemodynamic model via one or more hardware processors, in each cardiac cycle of an electrocardiogram (ECG) signal, cardiac parameters based on morphology of the ECG signal associated with a subject, wherein the cardiac parameters include a continuous heart rate (HR) and a set of compliance parameters, and wherein estimating the set of compliance parameters is based on: (i) a set of PQRST amplitudes; and (ii) time-instances, ([(α p j , t p j ), (α q j , t q j ), (α r j , t r j ), (α s j , t s j ), (α t j , t t j )]; j∈m) for a j th cardiac cycle (∀j∈m) of the ECG signal; generating, by the in-silico cardiovascular hemodynamic model via the one or more hardware processors, a set of compliance functions using the estimated cardiac parameters; sequentially activating, by the in-silico cardiovascular hemodynamic model via the one or more hardware processors, a plurality of cardiac chambers, in a synchronized manner, using the generated set of compliance functions; and estimating blood pressure of the subject, by the in-silico cardiovascular hemodynamic model via the one or more hardware processors, wherein the in-silico cardiovascular hemodynamic model is driven by the ECG signal associated with the subject. 2 . The processor implemented method of claim 1 , wherein the continuous HR is estimated based on the HR associated with a noise-less ECG signal, when the ECG signal is missing or is noisy, and is represented as: HR ⁡ ( t ) = { h a ⁢ e ⁢ ( e ⁢ n ⁢ d ) + w ⁢ ( t )   during ⁢   res ⁢ t ⁢ i ⁢ n ⁢ g ⁢   s ⁢ t ⁢ a ⁢ t ⁢ e [ 1 ⁢ - ( t + 1 ) ⁢ e - t τ k ] ⁢ h α ⁢ e ( 0 ) + w ⁡ ( t )   during ⁢   exe ⁢ r ⁢ c ⁢ i ⁢ s ⁢ i ⁢ n ⁢ g ⁢   s ⁢ t ⁢ a ⁢ t ⁢ e where, h ae (end), h ae (0) are the HRs at a last and a first instance of capturing the ECG signal respectively, w(t)= (0,σ 2 ) is white-noise with zero-mean, variance of σ 2 =9.26, and τ k =50 sec defines the time constant. σ 2 , and τ k are learnt empirically through the ECG signal using linear regression. 3 . The processor implemented method of claim 1 , wherein the set of compliance parameters of the j th cardiac cycle is estimated as T a j = t p j , d la j = g

Assignees

Inventors

Classifications

  • Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction · CPC title

  • Detecting abnormal QRS complex, e.g. widening · CPC title

  • Determining heart rate variability · CPC title

  • from analysis of pulse wave characteristics · CPC title

  • A61B5/7278Primary

    Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023397822A1 cover?
This disclosure relates generally to in-silico modeling of hemodynamic patterns of physiologic blood flow. Conventional cardiovascular hemodynamic models depend on neuromodulation schemes (baroreflex autoregulation) and threshold parameters of neuromodulation correlate with physical activities. Thus these models may not work practically for a large set of people due to dependency on prior knowl…
Who is the assignee on this patent?
Tata Consultancy Services Ltd
What technology area does this patent fall under?
Primary CPC classification A61B5/02028. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).